{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:26:54Z","timestamp":1780576014208,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.drudis.2023.103787","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T12:24:50Z","timestamp":1695385490000},"page":"103787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["ET-traps: Potential therapeutics for preeclampsia"],"prefix":"10.1016","volume":"28","author":[{"given":"Arjun","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9240-3140","authenticated-orcid":false,"given":"Ira","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2023.103787_b0005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/pr.115.011833","article-title":"Endothelin","volume":"68","author":"Davenport","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.drudis.2023.103787_b0010","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/HYPERTENSIONAHA.119.12105","article-title":"Endothelin: 30 years from discovery to therapy","volume":"74","author":"Barton","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.drudis.2023.103787_b0015","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/ajh.2011.99","article-title":"Endothelin: key mediator of hypertension in preeclampsia","volume":"24","author":"George","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.drudis.2023.103787_b0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.drudis.2023.103787_b0025","unstructured":"SA K, PL H. Preeclampsia. 2023;PMID: 34033373."},{"key":"10.1016\/j.drudis.2023.103787_b0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13522","article-title":"FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction","volume":"152","author":"Melamed","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.drudis.2023.103787_b0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.drudis.2023.103787_b0040","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1210\/jc.2004-1632","article-title":"Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia","volume":"90","author":"Fiore","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.drudis.2023.103787_b0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.preghy.2020.04.001","article-title":"Placental endothelin-converting enzyme-1 is decreased in preeclampsia","volume":"20","author":"McCormick","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.drudis.2023.103787_b0050","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.rbmo.2012.07.014","article-title":"Endothelin-1: a key pathological factor in pre-eclampsia?","volume":"25","author":"Jain","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.drudis.2023.103787_b0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/MNH.0000000000000197","article-title":"Role of endothelin in preeclampsia and hypertension following antiangiogenesis treatment","volume":"25","author":"Saleh","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.drudis.2023.103787_b0060","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.HYP.37.2.485","article-title":"Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure","volume":"37","author":"Alexander","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.drudis.2023.103787_b0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/HYPERTENSIONAHA.110.162321","article-title":"Maternal cardiac dysfunction and remodeling in women with preeclampsia at term","volume":"57","author":"Melchiorre","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.drudis.2023.103787_b0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ajpath.2017.11.008","article-title":"Fibrosis in preeclamptic placentas is associated with stromal fibroblasts activated by the transforming growth factor-\u03b21 signaling pathway","volume":"188","author":"Ohmaru-Nakanishi","year":"2018","journal-title":"Am J Pathol"},{"key":"10.1016\/j.drudis.2023.103787_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.664766","article-title":"Collagen I induces preeclampsia-like symptoms by suppressing proliferation and invasion of trophoblasts","volume":"12","author":"Feng","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.drudis.2023.103787_b0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MNH.0000000000000185","article-title":"Endothelin-1 and the kidney: new perspectives and recent findings","volume":"25","author":"De Miguel","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.drudis.2023.103787_b0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ki.2014.17","article-title":"Advances in the pathophysiology of pre-eclampsia and related podocyte injury","volume":"86","author":"Craici","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.drudis.2023.103787_b0090","doi-asserted-by":"crossref","first-page":"F1185","DOI":"10.1152\/ajprenal.00442.2007","article-title":"Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells","volume":"294","author":"Collino","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.drudis.2023.103787_b0095","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.ajpath.2012.03.005","article-title":"Endothelin-1 induces endoplasmic reticulum stress by activating the PLC-IP(3) pathway: implications for placental pathophysiology in preeclampsia","volume":"180","author":"Jain","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.drudis.2023.103787_b0100","doi-asserted-by":"crossref","first-page":"e13086","DOI":"10.1111\/obr.13086","article-title":"Endothelin-1 in the pathophysiology of obesity and insulin resistance","volume":"21","author":"Jenkins","year":"2020","journal-title":"Obes Rev"},{"key":"10.1016\/j.drudis.2023.103787_b0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40200-018-0360-8","article-title":"Endothelin-1 traps potently reduce pathologic markers back to basal levels in an in vitro model of diabetes","volume":"17","author":"Jain","year":"2018","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.drudis.2023.103787_b0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40200-019-00400-7","article-title":"In vivo studies demonstrate that endothelin-1 traps are a potential therapy for type I diabetes","volume":"18","author":"Jain","year":"2019","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.drudis.2023.103787_b0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0002-9378(97)80014-2","article-title":"Endothelin receptor A antagonism prevents hypoxia-induced intrauterine growth restriction in the rat","volume":"176","author":"Thaete","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.drudis.2023.103787_b0120","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/368703a0","article-title":"Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1","volume":"368","author":"Kurihara","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2023.103787_b0125","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1469-7793.2001.00579.x","article-title":"Endothelin-1-endothelin receptor type A mediates closure of rat ductus arteriosus at birth","volume":"537","author":"Taniguchi","year":"2001","journal-title":"J Physiol"},{"key":"10.1016\/j.drudis.2023.103787_b0130","article-title":"Association between proteinuria and maternal and neonatal outcomes in pre-eclampsia pregnancy: a retrospective observational study","volume":"48","author":"Xu","year":"2020","journal-title":"J Int Med Res"},{"key":"10.1016\/j.drudis.2023.103787_b0135","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.7150\/thno.61747","article-title":"Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.drudis.2023.103787_b0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/clpt.2011.66","article-title":"The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs","volume":"90","author":"Hutson","year":"2011","journal-title":"Clin Pharmacol Ther"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644623003033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644623003033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:10:54Z","timestamp":1761225054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644623003033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1359644623003033"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2023.103787","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ET-traps: Potential therapeutics for preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2023.103787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103787"}}